Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Invesco India Pharma And Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 07-Sep-26
Corpus(Cr.) 439.00 Latest NAV 9.54 As on 29-10-2026
Equity(%) 87.01 52 Week High 10.09
Debt(%) 12.99 52 Week Low 8.93
Others(%) 0.00 Exit Load 0.5% for redemption within 3 months
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Aditya Khemani
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 55.79%
Top 10 Holdings 91.07%
Top 25 Holdings 100.00%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Healthcare 45.62
Pharma & Biotech 41.39
Cash 12.99
 
 
 
 
 
Portfolio Metrics
PB Ratio 0.00
PE Ratio 0.00
 
Top 25 Holdings
Holdings Net Asset(%)
Triparty Repo 20.56
Max Healthcare Institute Limited 9.58
Sun Pharmaceutical Industries Ltd. 8.99
Sai Life Sciences Limited 8.63
Apollo Hospitals Enterprises Ltd. 8.03
Manipal Health Enterprises Limited 7.98
Divis Laboratories Ltd. 7.85
Global Health Limited 7.00
Dr. Agarwals Health Care Limited 6.32
Corona Remedies Limited 6.13
Torrent Pharmaceuticals Ltd. 4.93
Glenmark Pharmaceuticals ltd 4.86
Krishna Institute of Medical Sciences Limited 4.72
Aster DM Healthcare Limited 1.99
Net Receivables / (Payables) -7.57

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-3.15% 0.00% 0.00% 0.00%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [BSE Healthcare]
-3.04% -2.20% 11.33% 10.26%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
0.00% 0.00% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
7.24% 22.06% 14.69% 11.73%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection